Methyl CpG
Ortho Molecular Products' Methyl CpG is an 'Other Combinations' supplement with a focused blend of 5 ingredients. It boasts an N+ Score of 79, receiving a 'B-' grade, signifying a good quality product. This formulation excels in providing several key B vitamins at clinically studied dosages, including Riboflavin (25 mg), Vitamin B6 (50 mg), Folate (2000 mcg), and Vitamin B12 (1000 mcg), which research suggests may support methylation processes and nervous system health. The product also contains Betaine (500 mg). With full label transparency, this supplement may be particularly beneficial for individuals seeking comprehensive methylation support.
About This Product
Methyl CpG by Ortho Molecular Products is a vitamins & minerals supplement containing 5 active ingredients. It has earned an N+ Score of 79/100 (Grade B-).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Riboflavin, Vitamin B6, Folate and 1 more.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +4 ingredient(s) at clinical dose levels
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Riboflavin | 25.000 mg | Optimal |
| Vitamin B6 | 50.000 mg | Optimal |
| Folate | 2000.000 mcg | High |
| Vitamin B12 | 1000.000 mcg | Optimal |
| Betaine | 500.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
